John Franklin Fowler is CEO of Kezar Life Sciences, Inc.. Currently has a direct ownership of 393,904 shares of KZR, which is worth approximately $2.51 Million. The most recent transaction as insider was on Nov 10, 2022, when has been sold 27,000 shares (Common Stock) at a price of $0.9 per share, resulting in proceeds of $24,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 394K
0% 3M change
0% 12M change
Total Value Held $2.51 Million

John Franklin Fowler Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 10 2022
BUY
Exercise of conversion of derivative security
$24,300 $0.9 p/Share
27,000 Added 6.41%
393,904 Common Stock
Dec 14 2021
BUY
Exercise of conversion of derivative security
$6,930 $0.9 p/Share
7,700 Added 2.06%
366,904 Common Stock
Dec 31 2020
BUY
Exercise of conversion of derivative security
$14,400 $0.9 p/Share
16,000 Added 4.26%
359,204 Common Stock
JFF

John Franklin Fowler

CEO
South San Francisco, CA

Track Institutional and Insider Activities on KZR

Follow Kezar Life Sciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KZR shares.

Notify only if

Insider Trading

Get notified when an Kezar Life Sciences, Inc. insider buys or sells KZR shares.

Notify only if

News

Receive news related to Kezar Life Sciences, Inc.

Track Activities on KZR